๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Residual effects of lormetazepam on mood and performance in healthy elderly volunteers

โœ Scribed by J. B. Deijen; M. L. Heemstra; J. F. Orlebeke


Publisher
Springer
Year
1991
Tongue
English
Weight
548 KB
Volume
40
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

โœฆ Synopsis


45 subjects aged over 65 years were randomly assigned to treatment with lormetazepam 0.5 mg or 1 mg or placebo. Mood and performance were measured with a battery of computerized tests. Subjects were tested before and after 1 and 8 nights of treatment. Pre- and post-treatment scores were analysed by a multivariate covariance technique, the pre-treatment score serving as covariate. The single and repeated doses of lormetazepam resulted in impairment of performance in a memory task, and the repeated dose administration impaired performance of a perceptual task. The single administration of a low dose gave an improvement in fine motor control. No change was found in the mood states of the subjects.


๐Ÿ“œ SIMILAR VOLUMES


Effects of repeated dose nitrazepam and
โœ Kevin Morgan ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 294 KB

The daytime psychomotor performance of 12 healthy subjects of mean age 81.4 years was examined in a double-blind crossover study following single and repeated nightly doses of nitrazepam 5 mg, lormetazepam 1 mg, and placebo. Accuracy of performance on the Gibson spiral maze was unaffected by both dr

The effects of lormetazepam on contracti
โœ J. B. Deijen; M. L. Heemstra; Dr. J. F. Orlebeke; J. De Vries; J. B. M. Neijzen ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 584 KB

One group of 10 young subjects were tested twice; in one test session 2 mg lormetazepam, in the other session placebo was administered, in random order. One subject dropped out. In one test session contractile force measurements were made six times; one measurement took place before treatment and th

The effects of acute and repeated doses
โœ J. S. Kerr; D. B. Fairweather; I. Hindmarch ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 578 KB

The effects of moclobemide, a new selective and reversible MAO-A inhibitor, on cognitive function and psychomotor performance were measured in 12 healthy elderly male volunteers (with a mean age of 72.5 years). Subjects received moclobemide 200 mg, amitriptyline (positive internal control) 25 mg or

The effects of brofaromine alone and in
โœ J. S. Kerr; D. B. Fairweather; I. Hindmarch ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 662 KB

## Abstract Brofaromine is a novel antidepressant that functions by the inhibition of the A form of monoamine oxidase (MAO). This inhibition is reversible, making brofaromine both pharmacologically and structurally different from most of the currently available MAO inhibitors. The drug has been sho